Some very important and potentially game-changing legislation was recently passed. On Oct. 24, 2018, Congress enacted the Eliminating Kickbacks in Recovery Act of 2018 (or EKRA) – a statute that potentially eliminates legal protections (i.e., “safe harbors”) used by clinical laboratories to market their services. EKRA is part of the “Support for Patients and Communities Act,” comprehensive legislation designed toaddress the opioid crisis. The Act is clearly aimed at the use/abuse of opioids and the business practices of recovery centers.
Originally published from the Medical Association of the State of Alabama - March 2019.
Please see full publication below for more information.